Novel Replimune RP2 Treatment for Metastatic Uveal Melanoma
Replimune Presents Updated Data on RP2 in Uveal Melanoma during Plenary Session at the 20th International Congress of the Society for Melanoma Research Replimune Presents Updated Data on RP2 in Uveal Melanoma RP2 as monotherapy and in combination with nivolumab showed a favorable safety profile and durable responses in nearly 30 percent of [...]







